日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A pilot study of chemoimmunotherapy in the postconsolidation setting for high-risk neuroblastoma (ANBL19P1): A report from the Children's Oncology Group

一项针对高危神经母细胞瘤巩固治疗后化疗免疫疗法的试点研究(ANBL19P1):来自儿童肿瘤协作组的报告

Desai, Ami V; Naranjo, Arlene; LaBarre, Brian; Chen, Lulu; Goldsmith, Kelly C; Granger, Meaghan P; States, Lisa; Green, Sean G; Trunzo, Mariel; Fitzgerald, Wendy; DuBois, Steven G; Bagatell, Rochelle; Park, Julie R; Marachelian, Araz

Development and pilot testing of AYA-RISE, a risk information and screening education intervention for adolescents and young adults with cancer risk syndromes

AYA-RISE 的开发和试点测试,这是一项针对患有癌症风险综合征的青少年和年轻成人的风险信息和筛查教育干预措施。

Kamihara, Junne; Fisher, Lauren; Schienda, Jaclyn; Vanderwall, Rebecca; Snir, Moran; Snir, Guy; Simmons, Emilie; Khalaj, Andrew; Goler, Evan; Hamilton, Kayla V; Porter, Christopher C; Pencheva, Bojana; Schiffman, Joshua D; Maese, Luke D; Kohlmann, Wendy; Henderson, Tara O; Garber, Judy E; Diller, Lisa R; Desai, Ami V; Savage, Sarah; Klosky, James L; Rana, Huma Q; Mack, Jennifer W

Phase I Study of (131)I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

(131)I-间碘苄胍联合Dinutuximab±Vorinostat治疗复发或难治性神经母细胞瘤患者的I期研究:神经母细胞瘤治疗新方法试验

Cash Thomas, Marachelian Araz, DuBois Steven G, Chi Yueh-Yun, Baregamyan Anahit, Groshen Susan G, Jonus Hunter C, Shamirian Anasheh, Crowley Mary, Goodarzian Fariba, Acharya Patricia T, Pawel Bruce, Erbe Amy K, Shahi Ankita, Zaborek Jen, Kennedy Eleanor, Asgharzadeh Shahab, Villablanca Judith G, Pinto Navin, Weiss Brian D, Mosse Yael P, Desai Ami V, Macy Margaret E, Granger Meaghan, Vo Kieuhoa T, Sondel Paul M, Matthay Katherine K, Park Julie R, Goldsmith Kelly C

Racial and Ethnic Survival Disparities Among Children With High-Risk Neuroblastoma: A Children's Oncology Group Report

儿童肿瘤协作组关于高危神经母细胞瘤患儿种族和民族生存差异的报告

Umaretiya, Puja J; Naranjo, Arlene; Zhang, Fan F; Park, Julie R; Weiss, Brian D; Granger, Meaghan; Desai, Ami V; Ozkaynak, M Fevzi; Yu, Alice L; Aziz-Bose, Rahela; Pruitt, Sandi L; DuBois, Steven G; Bagatell, Rochelle; Bona, Kira

Extracting Electronic Health Record Neuroblastoma Treatment Data With High Fidelity Using the REDCap Clinical Data Interoperability Services Module

利用 REDCap 临床数据互操作性服务模块高保真地提取电子健康记录中的神经母细胞瘤治疗数据

Furner, Brian; Cheng, Alex; Desai, Ami V; Benedetti, Daniel J; Friedman, Debra L; Wyatt, Kirk D; Watkins, Michael; Volchenboum, Samuel L; Cohn, Susan L

Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531

对接受基于反应和生物学疗法的中危神经母细胞瘤患者进行长期随访:来自儿童肿瘤协作组研究 ANBL0531 的报告

Barr, Erin K; Naranjo, Arlene; Twist, Clare J; Tenney, Sheena C; Schmidt, Mary Lou; London, Wendy B; Gastier-Foster, Julie; Adkins, E Stanton; Mattei, Peter; Handler, Michael H; Matthay, Katherine K; Park, Julie R; Maris, John M; Desai, Ami V; Cohn, Susan L

Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials

儿童肿瘤协作组临床试验中接受治疗的高危神经母细胞瘤患儿的医疗保健利用差异

Shoag, Jamie; Li, Yimei; Getz, Kelly D; Huang, Yuan-Shung; Hall, Matt; Naranjo, Arlene; Richardson, Troy; Desai, Ami V; Umaretiya, Puja J; Aziz-Bose, Rahela; Kelly, Colleen A; Zheng, Daniel J; Newman, Haley; Zahler, Stacey; Aplenc, Richard; Bagatell, Rochelle; Bona, Kira

TRLS-12. EFFICACY AND SAFETY OF ENTRECTINIB IN CHILDREN WITHNTRK ORROS1 FUSION-POSITIVE (FP) PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

TRLS-12.恩曲替尼治疗NTRK ORROS1融合阳性(FP)原发性中枢神经系统(CNS)肿瘤患儿的疗效和安全性

Zou, Yuxin; Carbonetto, Peter; Xie, Dongyue; Wang, Gao; Stephens, Matthew; Chilukuri, Akanksha; Pomaville, Monica; Halbert, Matthew; He, Chaun; Agnihotri, Sameer; Huang, Tina; Piunti, Andrea; Qi, Jin; Bartom, Elizabeth; Saratsis, Amanda; Lopes, Carolina; Mosher, Amanda M; Papadakis, Joanna E; Keusch, Dylan; Largen, Kelsey; Weber, Daniel; Huang, Jesse; Yamini, Bakhtiar; Bauer, David; Danielpour, Moise; Sayama, Christina; Baird, Lissa; Bagchi, Aditi; Robinson, Giles W; Desai, Ami V; Wu, Yeming; Wang, Huanmin; Basu, Ellen M; Casanova, Michela; van Tilburg, Cornelis M; Campbell-Hewson, Quentin; Armstrong, Amy E; André, Nicolas; Devlin, Clare; Wulff, Jade; Cardenas, Alison; Hutchinson, Katherine E; Lian, Qinshu; Ryklansky, Carolina; Harmach, Vesna Sneller; Fox, Elizabeth; Gajjar, Amar

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results

劳拉替尼联合或不联合化疗治疗ALK驱动的难治性/复发性神经母细胞瘤:1期临床试验结果

Goldsmith, Kelly C; Park, Julie R; Kayser, Kimberly; Malvar, Jemily; Chi, Yueh-Yun; Groshen, Susan G; Villablanca, Judith G; Krytska, Kateryna; Lai, Lillian M; Acharya, Patricia T; Goodarzian, Fariba; Pawel, Bruce; Shimada, Hiroyuki; Ghazarian, Susan; States, Lisa; Marshall, Lynley; Chesler, Louis; Granger, Meaghan; Desai, Ami V; Mody, Rajen; Morgenstern, Daniel A; Shusterman, Suzanne; Macy, Margaret E; Pinto, Navin; Schleiermacher, Gudrun; Vo, Kieuhoa; Thurm, Holger C; Chen, Joseph; Liyanage, Marlon; Peltz, Gerson; Matthay, Katherine K; Berko, Esther R; Maris, John M; Marachelian, Araz; Mossé, Yael P

Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two Decades

二十年来,神经母细胞瘤患者的风险和生存率方面仍然存在种族和民族差异

Chennakesavalu, Mohansrinivas; Pudela, Caileigh; Applebaum, Mark A; Lee, Sang Mee; Che, Yan; Naranjo, Arlene; Park, Julie R; Volchenboum, Samuel L; Henderson, Tara O; Cohn, Susan L; Desai, Ami V